SecBot SecBot
SECBOTREPLAY Home › Report › MRK

MRK · Daiwa Capital double-upgraded Merck & Co

Merck & Co., Inc. · ANALYST-UPGRADE filed Aug 12, 2026 at 11:38 ET

At the news

BULLISHIMPACT 4/10

ANALYST-UPGRADE filed Aug 12, 2026 at 11:38 ET

Daiwa Capital double-upgraded Merck & Co. (MRK) from Neutral to Outperform on August 12, 2026, raising its price target to $143 from $120, implying 9.6% upside from the current $130.42. The firm has a 52% accuracy rate on 21 calls with a 6.7% average return. Consensus is bullish: 25 of 36 analysts rate MRK Buy or Strong Buy, 11 rate Hold, and none rate Sell. The mean target is $136.85, median $141.50, with a high of $155 and low of $105. Daiwa's $143 target sits above the mean but below the median. Momentum is positive with 1 upgrade and 0 downgrades in the past 30 days, though EPS revisions have been mixed with 2 downward revisions in the current quarter. Insider selling occurred on August 5-6, with five transactions totaling ~$3.3 million, including a $1.97 million sale by Guindo Chirfi. Institutional activity is mixed, with one large add and two trims. Short interest is elevated at 56.8% of TRF volume. The double upgrade from a moderately accurate firm is a notable bullish signal, but insider selling and high short interest warrant caution.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access